Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06379217 |
| Title | NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. |
| Recruitment | Active, not recruiting |
| Gender | male |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | GBR | FRA | ESP | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | United States | Details | |
| Memorial Sloan Kettering Cancer Ctr | New York | New York | 10017 | United States | Details | |
| Novartis Investigative Site | Nantes | 44093 | France | Details | ||
| Novartis Investigative Site | München | 80377 | Germany | Details | ||
| Novartis Investigative Site | Rostock | 18057 | Germany | Details | ||
| Novartis Investigative Site | L'Hospitalet de Llobregat | Barcelona | 08907 | Spain | Details | |
| Novartis Investigative Site | Madrid | 28041 | Spain | Details | ||
| Novartis Investigative Site | Sutton | Surrey | SM2 5PT | United Kingdom | Details | |
| Novartis Investigative Site | London | NW3 2QG | United Kingdom | Details |